Skip to content

Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00674960
Enrollment
0
Registered
2008-05-08
Start date
2008-05-31
Completion date
2009-10-31
Last updated
2009-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pick Disease of the Brain

Keywords

Brain Atrophy, Circumscribed Lobar, Circumscribed Lobar Atrophy of the Brain, Lobar Atrophy (Brain), Pick Disease, Pick's Disease, Picks Disease of Brain

Brief summary

Pick's disease, also known as Pick disease,or FTD is a rare fronto-temporal neurodegenerative disease. This study will investigate the use of far infrared radiation for the control, management and treatment of Pick's disease.

Detailed description

This disorder causes progressive destruction of nerve cells in the brain and causes tau proteins to accumulate into the Pick bodies that are a defining characteristic of the disease. Tau proteins are microtubule-associated proteins that are abundant in neurons in the central nervous system and are less common elsewhere. Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have FTD.

Interventions

RADIATIONRadiation: Far Infrared Radiation (5μm to 20μm wavelength)

Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.

Sponsors

GAAD Medical Research Institute Inc.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* People with Pick's Disease

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Therapy for FTD patients1 year

Secondary

MeasureTime frame
Rehabilitation of FTD Patients1 Year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026